School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Priyathama Vellanki

  • Department of Medicine
    Associate Professor
  • (404) 778-1687
  • priyathama.vellanki@emory.edu
Head shot of Priyathama Vellanki

Academic Appointment

  • Section Chief- Grady Endocrinology, Emory University School of Medicine
  • Medical Director- Grady Endocrinology Clinic, Emory University

Education

Degrees

  • BA from Rutgers University
  • MD from Robert Wood Johnson Medical School
  • MS from Northwestern University

Research

Publications

  • A mathematical model for ketosis-prone diabetes suggests the existence of multiple pancreatic -cell inactivation mechanisms.
    bioRxiv
    04/28/2025 Authors: Ridout SA; Vellanki P; Nemenman I
  • Assessment of Glycemic Control Using Continuous Glucose Monitoring During Hospitalization and After Discharge for Older Adults.
    J Diabetes Sci Technol Page(s): 19322968251332656
    04/12/2025 Authors: Kantipudi S; Idrees T; Castro-Revoredo I; Vellanki P; Castejon-Rosales E; Petty K; Peng L; Umpierrez GE
  • Estimation of Glucose Absorption, Insulin Sensitivity, and Glucose Effectiveness From the Oral Glucose Tolerance Test.
    J Clin Endocrinol Metab Volume: 110 Page(s): e1108 - e1115
    03/17/2025 Authors: Stefanovski D; Smiley DD; Punjabi NM; Umpierrez GE; Vellanki P
  • Randomized Study Comparing Continuous Glucose Monitoring and Capillary Glucose Testing in Patients With Type 2 Diabetes After Hospital Discharge.
    Endocr Pract Volume: 31 Page(s): 286 - 291
    03/01/2025 Authors: Umpierrez GE; Castro-Revoredo I; Moazzami B; Nayberg I; Zabala Z; Galindo RJ; Vellanki P; Peng L; Klonoff DC
  • Results From a Randomized Trial of Intensive Glucose Management Using CGM Versus Usual Care in Hospitalized Adults With Type 2 Diabetes: The TIGHT Study.
    Diabetes Care Volume: 48 Page(s): 118 - 124
    01/01/2025 Authors: Hirsch IB; Draznin B; Buse JB; Raghinaru D; Spanbauer C; Umpierrez GE; Ullal J; Jones MS; Low Wang CC; Spanakis EK
  • Low-added sugar dietary intervention study to mitigate glucose intolerance and improve body composition in adults with cystic fibrosis: a protocol of a double-blind, randomised study.
    BMJ Open Volume: 14 Page(s): e092503
    12/26/2024 Authors: Zaveri S; Stecenko A; Hunt WR; Goss A; Sharma P; Hartman TJ; Easley K; Chandler JD; Burley TM; Driggers C
  • Response to Comment on Kaminski et al. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes. Diabetes Care 2024;47:267-271.
    Diabetes Care Volume: 47 Page(s): e63 - e64
    08/01/2024 Authors: Vellanki P; Umpierrez GE
  • Continuous Glucose Monitoring-Guided Insulin Administration in Long-Term Care Facilities: A Randomized Clinical Trial.
    J Am Med Dir Assoc Volume: 25 Page(s): 884 - 888
    05/01/2024 Authors: Idrees T; Castro-Revoredo IA; Oh HD; Gavaller MD; Zabala Z; Moreno E; Moazzami B; Galindo RJ; Vellanki P; Cabb E
  • Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes.
    Diabetes Care Volume: 47 Page(s): 267 - 271
    02/01/2024 Authors: Kaminski CY; Galindo RJ; Navarrete JE; Zabala Z; Moazzami B; Gerges A; McCoy RG; Fayfman M; Vellanki P; Idrees T
  • Diabetic Ketoacidosis and Long-term Insulin Requirements in Youths with Newly Diagnosed Type 2 Diabetes During the SARS-CoV-2 Pandemic.
    Endocr Pract Volume: 29 Page(s): 754 - 761
    10/01/2023 Authors: Hao S; Cossen K; Westbrook AL; Umpierrez GE; Vellanki P
  • A Randomized Controlled Trial Comparing the Efficacy and Safety of IDegLira Versus Basal-Bolus in Patients With Poorly Controlled Type 2 Diabetes and Very High HbA1c 9-15%: DUAL HIGH Trial.
    Diabetes Care Volume: 46 Page(s): 1640 - 1645
    09/01/2023 Authors: Galindo RJ; Moazzami B; Scioscia MF; Zambrano C; Albury BS; Saling J; Vellanki P; Pasquel FJ; Davis GM; Fayfman M
  • Long-term insulin requirement after SARS-CoV-2 infection in youth with type 2 diabetes presenting with diabetic ketoacidosis
    Volume: 96 Page(s): 94 - 95
    07/26/2023 Authors: Hao S; Cossen K; Westbrook A; Umpierrez G; Vellanki P
  • Diabetic retinopathy in African-Americans with end-stage kidney disease: a cross-sectional study on prevalence and impact on quality of life.
    BMJ Open Diabetes Res Care Volume: 11
    07/01/2023 Authors: Egeolu M; Caleon RL; Manishimwe E; Zabala ZE; Moazzami B; Gerges A; O'Keefe GD; Navarrete J; Galindo RJ; McCoy RG
  • American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm - 2023 Update.
    Endocr Pract Volume: 29 Page(s): 305 - 340
    05/01/2023 Authors: Samson SL; Vellanki P; Blonde L; Christofides EA; Galindo RJ; Hirsch IB; Isaacs SD; Izuora KE; Low Wang CC; Twining CL
  • The effects of aging and frailty on inpatient glycemic control by continuous glucose monitoring in patients with type 2 diabetes.
    Diabetes Res Clin Pract Volume: 198 Page(s): 110603
    04/01/2023 Authors: Idrees T; Zabala ZE; Moreno EM; Gerges A; Urrutia MA; Ruiz JG; Vaughan C; Vellanki P; Pasquel FJ; Peng L
  • Intervention with Therapeutic Agents, Understanding the Path to Remission to Type 2 Diabetes: Part 2.
    Endocrinol Metab Clin North Am Volume: 52 Page(s): 39 - 47
    03/01/2023 Authors: Hao S; Umpierrez GE; Vellanki P
  • Intervention with Therapeutic Agents, Understanding the Path to Remission in Type 2 Diabetes: Part 1.
    Endocrinol Metab Clin North Am Volume: 52 Page(s): 27 - 38
    03/01/2023 Authors: Hao S; Umpierrez GE; Daley T; Vellanki P
  • SARS-CoV-2 does not increase severity of diabetic ketoacidosis in children and adolescents with new onset ketosis prone diabetes
    Volume: 365 Page(s): S68 - S68
    02/01/2023 Authors: Hao S; Cossen K; Vellanki P
  • Efficacy of a Smart Insulin Pen Cap for the Management of Patients with Uncontrolled Type 2 Diabetes: A Randomized Cross-Over Trial.
    J Diabetes Sci Technol Volume: 17 Page(s): 201 - 207
    01/01/2023 Authors: Galindo RJ; Ramos C; Cardona S; Vellanki P; Davis GM; Oladejo O; Albury B; Dhruv N; Peng L; Umpierrez GE
  • Quality of dietary macronutrients is associated with glycemic outcomes in adults with cystic fibrosis.
    Front Nutr Volume: 10 Page(s): 1158452
    01/01/2023 Authors: Daley TC; Cousineau BA; Nesbeth P-DC; Ivie EA; Bellissimo MP; Easley KA; Vellanki P; Vos MB; Hunt WR; Stecenko AA
  • Efficacy and Safety of Intensive Versus Nonintensive Supplemental Insulin With a Basal-Bolus Insulin Regimen in Hospitalized Patients With Type 2 Diabetes: A Randomized Clinical Study.
    Diabetes Care Volume: 45 Page(s): 2217 - 2223
    10/01/2022 Authors: Vellanki P; Cardona S; Galindo RJ; Urrutia MA; Pasquel FJ; Davis GM; Fayfman M; Migdal A; Peng L; Umpierrez GE
  • American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.
    Endocr Pract Volume: 28 Page(s): 923 - 1049
    10/01/2022 Authors: Blonde L; Umpierrez GE; Reddy SS; McGill JB; Berga SL; Bush M; Chandrasekaran S; DeFronzo RA; Einhorn D; Galindo RJ
  • Continuous Glucose Monitoring-Guided Insulin Administration in Hospitalized Patients With Diabetes: A Randomized Clinical Trial.
    Diabetes Care Volume: 45 Page(s): 2369 - 2375
    10/01/2022 Authors: Spanakis EK; Urrutia A; Galindo RJ; Vellanki P; Migdal AL; Davis G; Fayfman M; Idrees T; Pasquel FJ; Coronado WZ
  • Efficacy and safety of real-time continuous glucose monitoring guiding insulin administration in the hospital: a randomised clinical trial
    Volume: 65 Page(s): S53 - S53
    09/01/2022 Authors: Umpierrez GE; Galindo RJ; Urrutia MA; Vellanki P; Migdal AL; Davis GM; Pasquel FJ; Fayfman M; Idrees T; Peng L
  • Kynurenine Metabolism as a Mechanism to Improve Fatigue and Physical Function in Postmenopausal Breast Cancer Survivors Following Resistance Training.
    J Funct Morphol Kinesiol Volume: 7
    06/01/2022 Authors: Robbins RN; Kelleher JL; Vellanki P; O'Connor JC; Mascaro JS; Nocera JR; Serra MC
  • Inpatient Glycemic Control and Glucose Variability by Continuous Glucose Monitoring in Older Adults with Type 2 Diabetes
    Volume: 71
    06/01/2022 Authors: Idrees T; Galindo RJ; Urrutia MA; Castro-Revoredo IA; Moreno EM; Migdal AL; Davis GM; Vellanki P; Fayfman M; Pasquel FJ
  • Management of Inpatient Hyperglycemia Guided by Continuous Glucose Monitoring (CGM) in Insulin-Treated Patients with Diabetes-A Randomized Clinical Trial
    Volume: 71
    06/01/2022 Authors: Spanakis IE; Urrutia MA; Scioscia MF; Galindo RJ; Vellanki P; Migdal AL; Davis GM; Idrees T; Pasquel FJ; Singh LG
  • Insulin Secretion at Diabetes Remission in Obese Blacks Presenting with Diabetic Ketoacidosis
    Volume: 71
    06/01/2022 Authors: Stefanovski D; Oladejo O; Umpierrez GE; Vellanki P
  • Cell-Free DNA Methylation as a Biomarker of Islet-Cell Death in Youth with Type 2 Diabetes
    Volume: 71
    06/01/2022 Authors: Staimez LR; Ham JN; Daley T; Vellanki P; Smith AK; Narayan KMV; Baccarelli A; Conneely K
  • 1-h Glucose During Oral Glucose Tolerance Test Predicts Hyperglycemia Relapse-Free Survival in Obese Black Patients With Hyperglycemic Crises.
    Front Endocrinol (Lausanne) Volume: 13 Page(s): 871965
    01/01/2022 Authors: Jagannathan R; Stefanovski D; Smiley DD; Oladejo O; Cotten LF; Umpierrez G; Vellanki P
  • Degludec hospital trial: A randomized controlled trial comparing insulin degludec U100 and glargine U100 for the inpatient management of patients with type 2 diabetes.
    Diabetes Obes Metab Volume: 24 Page(s): 42 - 49
    01/01/2022 Authors: Galindo RJ; Pasquel FJ; Vellanki P; Alicic R; Lam DW; Fayfman M; Migdal AL; Davis GM; Cardona S; Urrutia MA
  • Diabetic ketoacidosis risk during the COVID-19 pandemic.
    Lancet Diabetes Endocrinol Volume: 9 Page(s): 643 - 644
    10/01/2021 Authors: Vellanki P; Umpierrez GE
  • Accuracy of Dexcom G6 Continuous Glucose Monitoring in Non-Critically Ill Hospitalized Patients With Diabetes.
    Diabetes Care Volume: 44 Page(s): 1641 - 1646
    07/01/2021 Authors: Davis GM; Spanakis EK; Migdal AL; Singh LG; Albury B; Urrutia MA; Zamudio-Coronado KW; Scott WH; Doerfler R; Lizama S
  • Biochemical Parameters of Diabetes Ketoacidosis in Patients with End-stage Kidney Disease and Preserved Renal Function.
    J Clin Endocrinol Metab Volume: 106 Page(s): e2673 - e2679
    06/16/2021 Authors: Galindo RJ; Pasquel FJ; Vellanki P; Zambrano C; Albury B; Perez-Guzman C; Ziduo Z; Umpierrez GE
  • Liraglutide hospital discharge trial: A randomized controlled trial comparing the safety and efficacy of liraglutide versus insulin glargine for the management of patients with type 2 diabetes after hospital discharge.
    Diabetes Obes Metab Volume: 23 Page(s): 1351 - 1360
    06/01/2021 Authors: Pasquel FJ; Urrutia MA; Cardona S; Coronado KWZ; Albury B; Perez-Guzman MC; Galindo RJ; Chaudhuri A; Iacobellis G; Palacios J
  • A Comparison of Cognitive Outcomes associated with Hypoglycemia among Younger and Older Adults
    Volume: 69 Page(s): S58 - S58
    04/01/2021 Authors: Garay PAS; Vellanki P; Cardona S; Umpierrez G; Ohuabunwa U
  • Sitagliptin for the prevention and treatment of perioperative hyperglycaemia in patients with type 2 diabetes undergoing cardiac surgery: A randomized controlled trial.
    Diabetes Obes Metab Volume: 23 Page(s): 480 - 488
    02/01/2021 Authors: Cardona S; Tsegka K; Pasquel FJ; Jacobs S; Halkos M; Keeling WB; Davis GM; Fayfman M; Albury B; Urrutia MA
  • A Case of Severe Hypocalcemia Caused by Malabsorption Due to Partial Gastrectomy and Small Bowel Resection.
    AACE Clin Case Rep Volume: 7 Page(s): 323 - 326
    01/01/2021 Authors: Knight JO; Cotten LF; Ziegler TR; Vellanki P
  • Clinical Case Report: Dissociation of Clinical Course of Coexisting Autoimmune Hepatitis and Graves Disease.
    AACE Clin Case Rep Volume: 7 Page(s): 36 - 39
    01/01/2021 Authors: Patel AM; Stanback C; Vellanki P
  • Differences in Oral Glucose Response Curve Shapes in African American Men and Women Presenting with Ketosis-Prone Diabetes
    Volume: 29 Page(s): A5 - A6
    12/01/2020 Authors: Vellanki P; Cotton L; Stefanovski D; Oladejo O; Umpierrez G
  • Comparison of the FreeStyle Libre Pro Flash Continuous Glucose Monitoring (CGM) System and Point-of-Care Capillary Glucose Testing in Hospitalized Patients With Type 2 Diabetes Treated With Basal-Bolus Insulin Regimen.
    Diabetes Care Volume: 43 Page(s): 2730 - 2735
    11/01/2020 Authors: Galindo RJ; Migdal AL; Davis GM; Urrutia MA; Albury B; Zambrano C; Vellanki P; Pasquel FJ; Fayfman M; Peng L
  • QUALITY OF DIETARY FATS AND OTHER MACRONUTRIENTS ARE ASSOCIATED WITH GLYCEMIC OUTCOMES IN ADULTS WITH CF
    Volume: 55 Page(s): S81 - S81
    10/01/2020 Authors: Daley T; Alvarez JA; Nesbeth P; Cousineau B; Bellissimo MP; Vellanki P; Vos M; Stecenko A; Ziegler TR; Ivie EA
  • Population insulin sensitivity from sparsely sampled oral glucose tolerance tests.
    Metabolism Volume: 110 Page(s): 154298
    09/01/2020 Authors: Stefanovski D; Vellanki P; Smiley-Byrd DD; Umpierrez GE; Boston RC
  • Safety And Efficacy Of Dpp-4 Inhibitors For The Management Of Hospitalized General Medicine And Surgery Patients with Type 2 Diabetes.
    Endocr Pract Volume: 26 Page(s): 722 - 728
    07/01/2020 Authors: Lorenzo-Gonzlez C; Atienza-Snchez E; Reyes-Umpierrez D; Vellanki P; Davis GM; Pasquel FJ; Cardona S; Fayfman M; Peng L; Umpierrez GE
  • Preparedness cycle to address transitions in diabetes care during the COVID-19 pandemic and future outbreaks.
    BMJ Open Diabetes Res Care Volume: 8
    07/01/2020 Authors: Gujral UP; Johnson L; Nielsen J; Vellanki P; Haw JS; Davis GM; Weber MB; Pasquel FJ
  • Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic.
    J Diabetes Sci Technol Volume: 14 Page(s): 822 - 832
    07/01/2020 Authors: Galindo RJ; Aleppo G; Klonoff DC; Spanakis EK; Agarwal S; Vellanki P; Olson DE; Umpierrez GE; Davis GM; Pasquel FJ
  • Home Diabetes Regimen and Admission HbA1c as Predictors of Hospital Glycemic Control: A Pooled Analysis of Inpatient Clinical Trials
    Volume: 69
    06/01/2020 Authors: Urrutia MA; Guo Y; Fayfman M; Vellanki P; Galindo RJ; Migdal A; Davis G; Anzola I; Albury BS; Scioscia MF
  • Immune Checkpoint Inhibitor Induced Diabetes and Diabetic Ketoacidosis
    Volume: 69
    06/01/2020 Authors: Hafeez S; Vellanki P; Xing M; Umpierrez GE
  • Randomized Controlled Trial on the Efficacy of Supplemental Rapid-Acting Insulin during Basal-Bolus Regimen in Non-ICU Patients with Type 2 Diabetes
    Volume: 69
    06/01/2020 Authors: Vellanki P; Cardona S; Urrutia MA; Galindo RJ; Davis G; Haw JS; Fayfman M; Migdal A; Guo Y; Pasquel FJ
  • The Shape of Glucose Response Curve during Oral Glucose Tolerance Tests (OGTT) and Long-Term Near-Normoglycemia Remission in African Americans Presenting with Hyperglycemic Crises
    Volume: 69
    06/01/2020 Authors: Cotten L; Stefanovski D; Oladejo O; Umpierrez GE; Vellanki P
  • A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial.
    Diabetes Care Volume: 43 Page(s): 1242 - 1248
    06/01/2020 Authors: Pasquel FJ; Lansang MC; Khowaja A; Urrutia MA; Cardona S; Albury B; Galindo RJ; Fayfman M; Davis G; Migdal A
  • Long-term changes in carbohydrate tolerance, insulin secretion and action in African-American patients with obesity and history of hyperglycemic crises.
    BMJ Open Diabetes Res Care Volume: 8
    05/01/2020 Authors: Vellanki P; Stefanovski D; Anzola II; Smiley DD; Peng L; Umpierrez GE
  • SAFETY AND EFFICACY OF DDP4-INHIBITORS FOR MANAGEMENT OF HOSPITALIZED GENERAL MEDICINE AND SURGERY PATIENTS WITH TYPE 2 DIABETES.
    Endocr Pract
    04/27/2020 Authors: Lorenzo-Gonzlez C; Atienza-Snchez E; Reyes-Umpierrez D; Vellanki P; Davis GM; Pasquel FJ; Cardona S; Fayfman M; Peng L; Umpierrez GE
  • Clinical characteristics and outcomes of patients with end-stage renal disease hospitalized with diabetes ketoacidosis.
    BMJ Open Diabetes Res Care Volume: 8
    02/01/2020 Authors: Galindo RJ; Pasquel FJ; Fayfman M; Tsegka K; Dhruv N; Cardona S; Wang H; Vellanki P; Umpierrez GE
  • Clinical Outcomes in Patients With Isolated or Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: A Retrospective, Hospital-Based Cohort Study.
    Diabetes Care Volume: 43 Page(s): 349 - 357
    02/01/2020 Authors: Pasquel FJ; Tsegka K; Wang H; Cardona S; Galindo RJ; Fayfman M; Davis G; Vellanki P; Migdal A; Gujral U
  • Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial.
    Circulation Volume: 140 Page(s): 1463 - 1476
    10/29/2019 Authors: Nassif ME; Windsor SL; Tang F; Khariton Y; Husain M; Inzucchi SE; McGuire DK; Pitt B; Scirica BM; Austin B
  • Glycemic Control During Gender-Affirming Therapy in a Patient With Type 1 Diabetes.
    Clin Diabetes Volume: 37 Page(s): 398 - 400
    10/01/2019 Authors: Campbell SH; Flint KL; Haw JS; Davis GM; Vellanki P
  • Sitagliptin for the Prevention and Treatment of Perioperative Hyperglycemia in Diabetic Patients Undergoing Cardiac Surgery
    Volume: 68
    06/01/2019 Authors: Cardona S; Tsegka KG; Jacobs S; Albury BS; Galindo RJ; Migdal A; Halkos ME; Keeling WB; Miller JS; Macheers SK
  • Accuracy Comparison of the Freestyle Libre Pro Continuous Glucose Monitoring (CGM) and Point-of-Care (POC) Testing in Noncritically Ill Hospitalized Patients with Type 2 Diabetes Treated with Basal-Bolus Insulin Regimen
    Volume: 68
    06/01/2019 Authors: Galindo RJ; Urrutia MA; Davis G; Khowaja A; Albury BS; Anzola I; Johnson AA; Vellanki P; Cardona S; Fayfman M
  • Differences in Glucose Absorption in African American (AA) Patients Presenting with DKA and Severe Hyperglycemia (SH)
    Volume: 68
    06/01/2019 Authors: Stefanovski D; Umpierrez GE; Boston RC; Vellanki P
  • A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients with Type 2 Diabetes: Glargine U300 Hospital Trial
    Volume: 68
    06/01/2019 Authors: Pasquel FJ; Lansang MC; Khowaja A; Galindo RJ; Urrutia MA; Cardona S; Shakally A; Lyerla RC; Anzola I; Albury BS
  • Normal Glucose Tolerance (NGT) in Obese African-Americans (AA) with Ketosis-Prone Diabetes (KPDM)
    Volume: 68
    06/01/2019 Authors: Vellanki P; Stefanovski D; Narwani V; Anzola I; Peng L; Smiley-Byrd D; Umpierrez GE
  • Glycaemic efficacy and safety of linagliptin compared to a basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: A multicentre randomized clinical trial.
    Diabetes Obes Metab Volume: 21 Page(s): 837 - 843
    04/01/2019 Authors: Vellanki P; Rasouli N; Baldwin D; Alexanian S; Anzola I; Urrutia M; Cardona S; Peng L; Pasquel FJ; Umpierrez GE
  • A Randomized Controlled Trial on the Safety and Efficacy of Exenatide Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes.
    Diabetes Care Volume: 42 Page(s): 450 - 456
    03/01/2019 Authors: Fayfman M; Galindo RJ; Rubin DJ; Mize DL; Anzola I; Urrutia MA; Ramos C; Pasquel FJ; Haw JS; Vellanki P
  • Comment on Desai et al. Health Care Utilization and Burden of Diabetic Ketoacidosis in the U.S. Over the Past Decade: A Nationwide Analysis. Diabetes Care 2018;41:1631-1638.
    Diabetes Care Volume: 42 Page(s): e24
    02/01/2019 Authors: Galindo RJ; Zambrano C; Vellanki P
  • Sitagliptin for the prevention of stress hyperglycemia in patients without diabetes undergoing coronary artery bypass graft (CABG) surgery.
    BMJ Open Diabetes Res Care Volume: 7 Page(s): e000703
    01/01/2019 Authors: Cardona S; Tsegka K; Pasquel FJ; Fayfman M; Peng L; Jacobs S; Vellanki P; Halkos M; Guyton RA; Thourani VH
  • Sitagliptin for prevention of stress hyperglycemia in patients without diabetes undergoing general surgery: A pilot randomized study.
    J Diabetes Complications Volume: 32 Page(s): 1091 - 1096
    12/01/2018 Authors: Fayfman M; Davis G; Duggan EW; Urrutia M; Chachkhiani D; Schindler J; Pasquel FJ; Galindo RJ; Vellanki P; Reyes-Umpierrez D
  • Sex- and Non Sex-Specific Differences in Carbohydrate Tolerance During Remission in Patients with Ketosis-Prone Diabetes
    Volume: 27 Page(s): 1432 - 1432
    11/01/2018 Authors: Vellanki P; Stefanovski D; Anzola I; Smiley DD; Peng L; Umpierrez GE
  • Glycaemic efficacy and safety of linagliptin compared to basal bolus insulin regimen in non-cardiac surgical patients with type 2 diabetes: Linagliptin-Surgery trial
    Volume: 61 Page(s): S377 - S378
    10/01/2018 Authors: Umpierrez G; Vellanki P; Rasouli N; Baldwin D; Alexanian S; Anzola I; Urrutia M; Gomez P; Cardona S; Wang H
  • Carbohydrate tolerance at near-normoglycaemia remission in obese African American patients with hyperglycaemic crises
    Volume: 61 Page(s): S340 - S340
    10/01/2018 Authors: Vellanki P; Stefanovski D; Narwani V; Anzola I; Smiley DD; Peng L; Umpierrez GE
  • Increasing Hospitalizations for DKA: A Need for Prevention Programs.
    Diabetes Care Volume: 41 Page(s): 1839 - 1841
    09/01/2018 Authors: Vellanki P; Umpierrez GE
  • Diabetes mellitus and insulin resistance in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Fertil Steril Volume: 110 Page(s): 523 - 533.e14
    08/01/2018 Authors: Yilmaz B; Vellanki P; Ata B; Yildiz BO
  • Clinical Outcomes and Mortality among Patients Hospitalized with Hypoglycemia and End-Stage Renal Disease in the US
    Volume: 67
    07/01/2018 Authors: Galindo RJ; Hurtado CR; Pasquel FJ; Vellanki P; Umpierrez GE
  • Clinical Characteristics and Outcomes in Patients Admitted with Diabetic Ketoacidosis (DKA) and End-Stage Renal Disease (ESRD)
    Volume: 67
    07/01/2018 Authors: Galindo RJ; Pasquel FJ; Tsegka KG; Cardona S; Dhruv N; Vellanki P; Fayfman M; Haw JS; Migdal A; Nair S
  • Safety and Efficacy of Exenatide Therapy for the Management of Hospitalized Patients with Type 2 Diabetes-Exenatide Hospital Trial
    Volume: 67
    07/01/2018 Authors: Fayfman M; Mize DL; Rubin DJ; Anzola I; Urrutia MA; Ramos C; Pasquel FJ; Haw JS; Vellanki P; Wang H
  • Simplified Transition Algorithm from Intravenous to Subcutaneous Insulin in Nondiabetic Cardiac Surgery Patients with Stress Hyperglycemia
    Volume: 67
    07/01/2018 Authors: Cardona S; Galindo RJ; Tsegka KG; Urrutia MA; Vellanki P; Fayfman M; Haw JS; Pasquel FJ; Peng L; Umpierrez GE
  • Characteristics and Mortality of Recurrent Diabetic Ketoacidosis (DKA) in Adults and Children with Type 1 Diabetes (T1D)
    Volume: 67
    07/01/2018 Authors: Vellanki P; Peng L; Dhruv N; Ramos C; Haw JS; Galindo RJ; Davis G; Fayfman M; Pasquel FJ; Umpierrez GE
  • Racial and Socioeconomic Disparities in Meeting Goals of Care in Adults with Type 1 Diabetes
    Volume: 67
    07/01/2018 Authors: Haw JS; Peng L; Pasquel FJ; Vellanki P; Fayfman M; Davis G; Umpierrez GE
  • Validation of data from electronic data warehouse in diabetic ketoacidosis: Caution is needed.
    J Diabetes Complications Volume: 32 Page(s): 650 - 654
    07/01/2018 Authors: VanderWeele J; Pollack T; Oakes DJ; Smyrniotis C; Illuri V; Vellanki P; O'Leary K; Holl J; Aleppo G; Molitch ME
  • THE EFFICACY AND SAFETY OF CO-ADMINISTRATION OF SITAGLIPTIN WITH METFORMIN IN PATIENTS WITH TYPE 2 DIABETES AT HOSPITAL DISCHARGE.
    Endocr Pract Volume: 24 Page(s): 556 - 564
    06/01/2018 Authors: Gianchandani RY; Pasquel FJ; Rubin DJ; Dungan KM; Vellanki P; Wang H; Anzola I; Gomez P; Hodish I; Lathkar-Pradhan S
  • A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial.
    J Am Med Dir Assoc Volume: 19 Page(s): 399 - 404.e3
    05/01/2018 Authors: Umpierrez GE; Cardona S; Chachkhiani D; Fayfman M; Saiyed S; Wang H; Vellanki P; Haw JS; Olson DE; Pasquel FJ
  • Stress hyperglycemia in general surgery: Why should we care?
    J Diabetes Complications Volume: 32 Page(s): 305 - 309
    03/01/2018 Authors: Davis G; Fayfman M; Reyes-Umpierrez D; Hafeez S; Pasquel FJ; Vellanki P; Haw JS; Peng L; Jacobs S; Umpierrez GE
  • Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Fertil Steril Volume: 109 Page(s): 356 - 364.e32
    02/01/2018 Authors: Yilmaz B; Vellanki P; Ata B; Yildiz BO
  • Clinical characteristics and outcomes of symptomatic and asymptomatic hypoglycemia in hospitalized patients with diabetes.
    BMJ Open Diabetes Res Care Volume: 6 Page(s): e000607
    01/01/2018 Authors: Cardona S; Gomez PC; Vellanki P; Anzola I; Ramos C; Urrutia MA; Haw JS; Fayfman M; Wang H; Galindo RJ
  • DIABETIC KETOACIDOSIS: A COMMON DEBUT OF DIABETES AMONG AFRICAN AMERICANS WITH TYPE 2 DIABETES.
    Endocr Pract Volume: 23 Page(s): 971 - 978
    08/01/2017 Authors: Vellanki P; Umpierrez GE
  • Efficacy and Safety of Linagliptin in General Surgical Patients with Type 2 Diabetes: Linagliptin Surgery Trial
    Volume: 66 Page(s): A336 - A336
    06/01/2017 Authors: Vellanki P; Alexanian S; Baldwin D; Rasouli N; Anzola IA; Ramos C; Urrutia MA; Jones J; Modzelewski K; Ensminger E
  • A Randomized Controlled Study Comparing Linagliptin and Glargine Insulin in Long-Term Care Residents with Type 2 Diabetes
    Volume: 66 Page(s): A341 - A341
    06/01/2017 Authors: Umpierrez GE; Chachkhiani D; Cardona S; Saiyed S; Wang H; Johnson T; Doan J; Vellanki P; Fayfman M; Haw S
  • Asymptomatic Hypoglycemia in Non-ICU Patients with Diabetes
    Volume: 66 Page(s): A109 - A109
    06/01/2017 Authors: Haw JS; Gomez P; Anzola I; Ramos C; Urrutia M; Cardona S; Vellanki P; Pasquel F; Fayfman M; Wang H
  • DPP-4 Inhibitors for the Inpatient Management of General Medicine and Surgery Patients with Type 2 Diabetes
    Volume: 66 Page(s): A342 - A343
    06/01/2017 Authors: Reyes-Umpierrez D; Davis G; Peng L; Pasquel F; Vellanki P; Jacobs S; Fayfman M; Haw S; Umpierrez GE
  • Sitagliptin for the Prevention of Stress Hyperglycemia in Nondiabetic Patients Undergoing Cardiac Surgery
    Volume: 66 Page(s): A341 - A341
    06/01/2017 Authors: Cardona S; Tsegka K; Thourani VH; Halkos M; Guyton RA; Pasquel FJ; Vellanki P; Fayfman M; Haw JS; Peng L
  • Transition of Diabetes Care in Surgery Patients with Type 2 Diabetes (T2D) Using an HbA1c-Based Algorithm
    Volume: 66 Page(s): LB44 - LB44
    06/01/2017 Authors: Rasouli N; Vellanki P; Alexanian S; Baldwin D; Anzola I; Ramos C; Urrutia MA; Modzelewski K; Pasquel FJ; Fayfman M
  • Exaggerated glucagon responses to hypoglycemia in women with polycystic ovary syndrome.
    Metabolism Volume: 71 Page(s): 125 - 131
    06/01/2017 Authors: Sam S; Vellanki P; Yalamanchi SK; Bergman RN; Dunaif A
  • Treatment of Diabetic Ketoacidosis (DKA)/Hyperglycemic Hyperosmolar State (HHS): Novel Advances in the Management of Hyperglycemic Crises (UK Versus USA).
    Curr Diab Rep Volume: 17 Page(s): 33
    05/01/2017 Authors: Dhatariya KK; Vellanki P
  • Hospitalization costs and clinical outcomes in CABG patients treated with intensive insulin therapy.
    J Diabetes Complications Volume: 31 Page(s): 742 - 747
    04/01/2017 Authors: Cardona S; Pasquel FJ; Fayfman M; Peng L; Jacobs S; Vellanki P; Weaver J; Halkos M; Guyton RA; Thourani VH
  • HOSPITAL DISCHARGE ALGORITHM BASED ON ADMISSION HBA1C FOR THE MANAGEMENT OF PATIENTS WITH TYPE 2 DIABETES; SITAGLIPTIN SITAGLIPTIN DISCHARGE TRIAL
    Volume: 65 Page(s): 632 - 633
    02/01/2017 Authors: Cardona SD; Vellanki P; Anzola I; Gomez P; Pasquel F; Umpierrez GE
  • CLINICAL CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH COMBINED DIABETIC KETOACIDOSIS AND HYPEROSMOLAR HYPERGLYCEMIC CRISES
    Volume: 65 Page(s): 634 - 634
    02/01/2017 Authors: Tsegka K; Cardona SD; Nair S; Vellanki P; Narayan K; Umpierrez GE; Pasquel F
  • USE OF ORAL AGENTS (DIPEPTIDYL PEPTIDASE 4 INHIBITORS) FOR THE MANAGEMENT OF PATIENTS WITH TYPE 2 DIABETES: SITA-HOSPITAL TRIAL
    Volume: 65 Page(s): 632 - 632
    02/01/2017 Authors: Anzola I; Pasquel F; Gomez P; Peng L; Haw J; Fayfman M; Vellanki P; Umpierrez GE
  • PERIOPERATIVE STRESS HYPERGLYCEMIA AND RISK OF COMPLICATIONS AND MORTALITY IN NON-DIABETIC PATIENTS UNDERGOING GENERAL SURGERY
    Volume: 65 Page(s): 635 - 635
    02/01/2017 Authors: Davis G; Fayfman M; Reyes D; Pasquel F; Vellanki P; Haw J; Peng L; Umpierrez GE
  • Inflammation and Oxidative Stress in Cardiac Surgery Patients Treated to Intensive Versus Conservative Glucose Targets.
    J Clin Endocrinol Metab Volume: 102 Page(s): 309 - 315
    01/01/2017 Authors: Reyes-Umpierrez D; Davis G; Cardona S; Pasquel FJ; Peng L; Jacobs S; Vellanki P; Fayfman M; Haw S; Halkos M
  • Randomized Controlled Study of Metformin and Sitagliptin on Long-term Normoglycemia Remission in African American Patients With Hyperglycemic Crises.
    Diabetes Care Volume: 39 Page(s): 1948 - 1955
    11/01/2016 Authors: Vellanki P; Smiley DD; Stefanovski D; Anzola I; Duan W; Hudson M; Peng L; Pasquel FJ; Umpierrez GE
  • Detemir is non-inferior to NPH insulin in women with pregestational type 2 diabetes and gestational diabetes mellitus.
    Evid Based Med Volume: 21 Page(s): 104 - 105
    06/01/2016 Authors: Vellanki P; Umpierrez G
  • Metabolic Pathways Associated with Diabetic Ketoacidosis (DKA) Severity and DKA Resolution (DKA)
    Volume: 65 Page(s): A413 - A413
    06/01/2016 Authors: Pasquel FJ; Chong EY; Vellanki P; Jones DP; Ziegler TR; Umpierrez GE
  • Perioperative Stress Hyperglycemia and Risk of Complications and Mortality in Nondiabetic Patients Undergoing General Surgery
    Volume: 65 Page(s): A384 - A385
    06/01/2016 Authors: Davis G; Fayfman M; Reyes D; Pasquel F; Vellanki P; Haw S; Peng L; Umpierrez GE
  • Gene Expression Changes and Insulin Remission in Patients with Ketosis-Prone Diabetes
    Volume: 65 Page(s): A428 - A428
    06/01/2016 Authors: Vellanki P; Parets SE; Smiley DD; Pasquel FJ; Anzola I; Smith AK; Umpierrez GE
  • Acute and Long-Term Neuroanatomical and Cognitive Changes in Adult Patients with First and Recurrent Episodes of Diabetic Ketoacidosis (DKA)
    Volume: 65 Page(s): A203 - A203
    06/01/2016 Authors: Ennis GE; Allen JW; Doan J; Behbahani K; Chachkhiani D; Powell W; Haw JS; Pasquel F; Vellanki P; Fayfman M
  • Validation of Electronic Medical Record Data in Diabetic Ketoacidosis
    Volume: 65 Page(s): A384 - A384
    06/01/2016 Authors: Vanderweele J; Derby T; Oakes DJ; Smyrniotis C; Illuri VD; Vellanki P; O'Leary K; Holl J; Aleppo G; Molitch ME
  • Asymptomatic Hypoglycemia in Hospitalized Patients with Diabetes: Prevalence, Risk Factors, and Outcomes
    Volume: 65 Page(s): A543 - A543
    06/01/2016 Authors: Gomez PC; Anzola I; Urrutia MA; Fayfman M; Vellanki P; Pasquel F; Haw S; Peng L; Umpierrez GE
  • Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome: Clinical Characteristics and Outcome
    Volume: 65 Page(s): A387 - A387
    06/01/2016 Authors: Pasquel FJ; Vellanki P; Fayfman M; Oyedokun F; Haw S; Narayan KMV; Umpierrez GE
  • Report on Racial Disparities in Hospitalized Patients with Hyperglycemia and Diabetes.
    J Clin Endocrinol Metab Volume: 101 Page(s): 1144 - 1150
    03/01/2016 Authors: Fayfman M; Vellanki P; Alexopoulos A-S; Buehler L; Zhao L; Smiley D; Haw S; Weaver J; Pasquel FJ; Umpierrez GE
  • Impact of obesity on hospital complications and mortality in hospitalized patients with hyperglycemia and diabetes.
    BMJ Open Diabetes Res Care Volume: 4 Page(s): e000200
    01/01/2016 Authors: Alexopoulos A-S; Fayfman M; Zhao L; Weaver J; Buehler L; Smiley D; Pasquel FJ; Vellanki P; Haw JS; Umpierrez GE
  • Predictive Value of Admission Hemoglobin A1c on Inpatient Glycemic Control and Response to Insulin Therapy in Medicine and Surgery Patients With Type 2 Diabetes.
    Diabetes Care Volume: 38 Page(s): e202 - e203
    12/01/2015 Authors: Pasquel FJ; Gomez-Huelgas R; Anzola I; Oyedokun F; Haw JS; Vellanki P; Peng L; Umpierrez GE
  • COMPARISON OF BASAL INSULIN REGIMENS ON GLYCEMIC VARIABILITY IN NONCRITICALLY ILL PATIENTS WITH TYPE 2 DIABETES.
    Endocr Pract Volume: 21 Page(s): 1333 - 1343
    12/01/2015 Authors: Haw JS; Farrokhi F; Smiley D; Peng L; Reyes D; Newton C; Pasquel FJ; Vellanki P; Umpierrez GE
  • National Strategies to Decrease the Burden of Diabetes and Its Complications.
    Curr Diab Rep Volume: 15 Page(s): 65
    09/01/2015 Authors: Haw JS; Tantry S; Vellanki P; Pasquel FJ
  • Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCO-CABG Trial.
    Diabetes Care Volume: 38 Page(s): 1665 - 1672
    09/01/2015 Authors: Umpierrez G; Cardona S; Pasquel F; Jacobs S; Peng L; Unigwe M; Newton CA; Smiley-Byrd D; Vellanki P; Halkos M
  • Efficacy and Safety of Oral Antidiabetic Drug Therapy in General Hospitalized Population with Type 2 Diabetes
    Volume: 64 Page(s): A329 - A329
    06/01/2015 Authors: Pasquel F; Fayfman M; Vellanki P; Haw S; Smiley DD; Zhao L; Nair S; Weaver J; Umpierrez GE
  • Hypoglycemia between Treatment with Oral Agents and Basal Insulin in Elderly Patients with Type 2 Diabetes in Long-Term Care Facilities
    Volume: 64 Page(s): A106 - A106
    06/01/2015 Authors: Pasquel FJ; Powell W; Smiley DD; Peng L; Vellanki P; Haw S; Umpierrez GE; Doan J
  • Body Mass Index, Diabetes Type, and Mortality after Cardiac Transplantation
    Volume: 64 Page(s): A477 - A477
    06/01/2015 Authors: Galindo RJ; Harris YT; Wallia A; Stein J; Vellanki P; Umpierrez GE
  • Randomized controlled trial of insulin supplementation for correction of bedtime hyperglycemia in hospitalized patients with type 2 diabetes.
    Diabetes Care Volume: 38 Page(s): 568 - 574
    04/01/2015 Authors: Vellanki P; Bean R; Oyedokun FA; Pasquel FJ; Smiley D; Farrokhi F; Newton C; Peng L; Umpierrez GE
  • Iatrogenic hypoglycemia and quality of life in patients with type 2 diabetes mellitus.
    Rev Clin Esp (Barc) Volume: 215 Page(s): 104 - 106
    03/01/2015 Authors: Vellanki P; Umpierrez GE
  • The impact of hyperglycemia and obesity on hospitalization costs and clinical outcome in general surgery patients.
    J Diabetes Complications Volume: 29 Page(s): 1177 - 1182
    01/01/2015 Authors: Buehler L; Fayfman M; Alexopoulos A-S; Zhao L; Farrokhi F; Weaver J; Smiley-Byrd D; Pasquel FJ; Vellanki P; Umpierrez GE
  • Parent-of-origin effects on glucose homeostasis in polycystic ovary syndrome.
    J Clin Endocrinol Metab Volume: 99 Page(s): 2961 - 2966
    08/01/2014 Authors: Kobaly K; Vellanki P; Sisk RK; Armstrong L; Lee JY; Lee J; Hayes MG; Urbanek M; Legro RS; Dunaif A
  • Obese Women with PCOS Have Reduced Liver Glucokinase Activity
    ENDOCRINE REVIEWS Volume: 35
    06/01/2014 Authors: Vellanki P; Stefanovski D; Bergman RN; Dunaif A
  • Mapping Missing Heritability in PCOS: Developing Interpretive and Validation Methodology for Identifying the Contribution of Rare Variants to PCOS
    ENDOCRINE REVIEWS Volume: 35
    06/01/2014 Authors: Daviau E; Vellanki P; Torchen L; Sisk R; Werstein B; Legro RS; Urbanek M; Hayes MG; Dunaif A
  • Association of Glycemic Control, Inflammatory Markers and Peri-Operative Complications in Patients Undergoing CABG
    ENDOCRINE REVIEWS Volume: 35
    06/01/2014 Authors: Pasquel FJ; Vellanki P; Cardona S; Anzola I; Fayfman M; Peng L; Smiley D; Umpierrez GE
  • Assessing Current Management of Inpatient Diabetic Ketoacidosis Using Quality Improvement Methodology
    DIABETES Volume: 63 Page(s): A622 - A622
    06/01/2014 Authors: Therasse A; Vellanki P; Springer EJ; Oakes DJ; O'Leary K; Molitch ME; Holl J; Aleppo G; Wallia A
  • Denosumab for management of parathyroid carcinoma-mediated hypercalcemia.
    J Clin Endocrinol Metab Volume: 99 Page(s): 387 - 390
    02/01/2014 Authors: Vellanki P; Lange K; Elaraj D; Kopp PA; El Muayed M
  • FASTING GLUCOSE LEVELS DO NOT PREDICT IMPAIRED GLUCOSE TOLERANCE (IGT) IN POLYCYSTIC OVARY SYNROME (PCOS)
    Volume: 100 Page(s): S361 - S361
    09/01/2013 Authors: Kuang H; Vellanki P; Dodson WC; Kunselman AR; Dunaif A; Legro RS
  • Familial aggregation of circulating C-reactive protein in polycystic ovary syndrome.
    Hum Reprod Volume: 28 Page(s): 770 - 776
    03/01/2013 Authors: Sasidevi A; Vellanki P; Kunselman AR; Raja-Khan N; Dunaif A; Legro RS
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements